No credit card. No commitment.
5000+ G2 reviews
ATS GmbH
Pharmaceuticals
Founded in 2020
Duesseldorf, North Rhine-WestphaliaATS GmbH
PharmaceuticalsFounded in 2020Duesseldorf, North Rhine-Westphalia
TechnologiesATS GmbH's financial review
Employees
4
ATS GmbH information
We (ATS GmbH) are German private label company that has manufacturing contracts from many European manufactures. Our main target market is Iraq and some other middle east countries.We have currently supplement product line as well as injection products, mainly antibiotics, and we are planning to develop anaesthesia due to the extreme shortage of anesthetise product in the Iraqi market.In the Iraqi...
We (ATS GmbH) are German private label company that has manufacturing contracts from many European manufactures. Our main target market is Iraq and some other middle east countries.We have currently supplement product line as well as injection products, mainly antibiotics, and we are planning to develop anaesthesia due to the extreme shortage of anesthetise product in the Iraqi market.In the Iraqi market, we run a business and access to About 175 Governmental & Private Hospitals, about 7200 Independent pharmacies, and about 851 Wholesalers (Drug Stores).More information about our company are available in our website (https://www.atsde.com/).
ATS GmbH industries
Pharmaceuticals
Pharmaceutical manufacturing
Medical
ATS GmbH's financial review
Employees
4
Technologies
Email Providers
Other
Hosting
CMS
Load Balancers
Other
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
